Obesity, Childhood
Conditions
Brief summary
This project aims to move what is currently a specialty-care model for the management of obesity of children and adolescents into the primary care setting.
Detailed description
The goal of this project is to create a sustainable clinical model in the primary care setting that improves nutritional health, lessens obesity, and addresses weight-related complications of children and adolescents to reduce risk for metabolic disease in later life. The primary objectives include tracking changes in BMI (both absolute and percentile) and levels of hemoglobin A1c, liver enzymes (AST, ALT levels), and lipids in patients seen in a primary care setting by a general pediatrician board-certified in obesity medicine. Secondary objectives include tracking patient adherence, follow-up, and retention.
Interventions
Dietician visits, education, anti-obesity medications, and/or referral for metabolic-bariatric surgery as indicated by American Academy of Pediatrics guidelines for obesity management.
Sponsors
Study design
Eligibility
Inclusion criteria
Children with obesity (BMI \> 30 kg/m2 or \> 95th percentile) or in need of weight management of unwanted weight gain.
Exclusion criteria
None.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in BMI | Baseline to follow-up (1-3 years) | BMI will be calculated using the formula: kg weight / m2 height. Will be in both absolute and percentile for age |
| Change in body weight | Baseline to follow-up (1-3 years) | Body weight in kg |
| Change in body height | Baseline to follow-up (1-3 years) | Body height in meters |
| Impact on lipid levels | Baseline to follow-up (1-3 years) | Levels of total, LDL, HDL, and non-HDL cholesterol. Triglycerides. |
| Impact on glucose control | Baseline to follow-up (1-3 years) | Hemoglobin A1c levels |
| Impact on fatty liver | Baseline to follow-up (1-3 years) | Levels of liver enzymes ALT, AST |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient follow-up metrics | Baseline to follow-up (1-3 years) | Patient clinical follow-up rate, medication adherence, and retention |
Countries
United States